Evidence map›Paper›PMID 40869611›Full record

ReviewJournal of clinical medicine2025

Bone Health in Metabolic Syndrome-Is It a Neglected Aspect of Dysmetabolic-Related Diseases?

Emilia Biamonte, Giulia Bendotti, Giulia Nigro, Beatrice Cavigiolo, Marco Gallo

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emilia BiamonteEndocrinology and Metabolic Diseases Unit, Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.
Giulia BendottiEndocrinology and Metabolic Diseases Unit, Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.ORCID 0000-0002-6548-3475
Giulia NigroMetabolic and Nutritional Disease Unit, ASST Bergamo EST, Ospedale Bolognini, 24068 Seriate, Italy.
Beatrice CavigioloEndocrinology and Metabolic Diseases Unit, ASL Vercelli, 13100 Vercelli, Italy.
Marco GalloEndocrinology and Metabolic Diseases Unit, Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.ORCID 0000-0001-7166-0848

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to their widespread prevalence and the aging global population, metabolic syndrome (MetS) and osteoporosis represent significant public health challenges. Clinical interest in MetS is currently primarily focused on cardiovascular risks. However, emerging evidence indicates that metabolic conditions may also adversely affect bone health. Each component of MetS-especially glucose metabolism impairment, central obesity, and endocrine factors-impacts bones in distinct ways, creating a complex network of interactions that influences skeletal health. These metabolic disturbances can lead to changes in bone remodeling, potentially resulting in alterations to bone mineral density and microarchitectural structure and an increased risk of fractures. Regarding uncertain and controversial pieces of evidence about the effect of MetS on bone health, this narrative review discusses and summarizes the current research on the association of MetS and its components with bone metabolism, bone quantity (based on bone mineral density, or BMD), bone quality (based on trabecular bone score, or TBS), and fracture risk.

Indexed as

bone healthdyslipidemiafracture riskhypertensioninsulin resistancemetabolic syndromemineral densityobesityosteoporosistrabecular bone score

Identifiers

PMID40869611
PMCPMC12386887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.